Impaired lipolysis in propionic acidemia: A new metabolic myopathy?

Autor: Jesper H. Storgaard, Karen L. Madsen, Nicoline Løkken, John Vissing, Gerrit vanHall, Allan M. Lund, Mette C. Ørngreen

Publikováno v: JIMD Reports, Vol 53, Iss 1, Pp 16-21 (2020)

Abstract The objective of this study was to investigate the fat and carbohydrate metabolism in a patient with propionic acidemia (PA) during exercise by means of indirect calorimetry and stable isotope technique. A 34‐year‐old patient with PA per

Externí odkaz: https://doaj.org/article/f36ea353935c44c59082e2eb58ff3854

No effect of resveratrol on fatty acid oxidation or exercise capacity in patients with fatty acid oxidation disorders:A randomized clinical cross-over trial

Autor: Jesper H. Storgaard, Nicoline Løkken, Karen L. Madsen, Nicol C. Voermans, Pascal Laforêt, Aleksandra Nadaj‐Pakleza, Céline Tard, Gerrit van Hall, John Vissing, Mette C. Ørngreen

Publikováno v: Storgaard, J H, Løkken, N, Madsen, K L, Voermans, N C, Laforêt, P, Nadaj-Pakleza, A, Tard, C, van Hall, G, Vissing, J & Ørngreen, M C 2022, ' No effect of resveratrol on fatty acid oxidation or exercise capacity in patients with fatty acid oxidation disorders : A randomized clinical cross-over trial ', Journal of Inherited Metabolic Disease, vol. 45, no. 3, pp. 517-528 . https://doi.org/10.1002/jimd.12479
Journal of Inherited Metabolic Disease, 45, 517-528
Journal of Inherited Metabolic Disease, 45, 3, pp. 517-528

Contains fulltext : 252095.pdf (Publisher’s version ) (Open Access) The objective was to investigate whether resveratrol (RSV) can improve exercise capacity in patients with fatty acid oxidation (FAO) disorders. The study was a randomized, double-b

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35c7f1c8f8052d68acf3e19caf6f0866
https://curis.ku.dk/portal/da/publications/no-effect-of-resveratrol-on-fatty-acid-oxidation-or-exercise-capacity-in-patients-with-fatty-acid-oxidation-disorders(e9d4912e-1dc2-4b05-bd84-ea2887faf2cb).html

Muscle phenotype in patients with myotonic dystrophy type 1

Autor: Grete, Andersen, Mette C, Ørngreen, Nicolai, Preisler, Eskild, Colding-Jørgensen, Torben, Clausen, Morten, Duno, Tina D, Jeppesen, John, Vissing

Publikováno v: Musclenerve. 47(3)

The pathogenesis of muscle involvement in patients with myotonic dystrophy type 1 (DM1) is not well understood. In this study, we characterized the muscle phenotype in patients with confirmed DM1.In 38 patients, muscle strength was tested by hand-hel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f3f70b7f0bedf2ee1ad63de8220c38ed
https://pubmed.ncbi.nlm.nih.gov/23169601

Fuel utilization in patients with very long-chain acyl-coa dehydrogenase deficiency

Autor: Mette C, ØRngreen, Mette G, Nørgaard, Massimo, Sacchetti, Baziel G M, van Engelen, John, Vissing

Publikováno v: Annals of neurology. 56(2)

Fuel utilization in two adult patients with the myopathic form of very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency and five healthy subjects was investigated with stable isotopes during exercise at 50% of VO2max. The findings indicate that r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::44fca04ab4dbe47d46861c3ef19f7e83
https://pubmed.ncbi.nlm.nih.gov/15293280

Fuel utilization in patients with very long?chain acyl?coa dehydrogenase deficiency.

Autor: Mette C. ØRngreen, Mette G. Nørgaard, Massimo Sacchetti, Baziel G. M. Van Engelen, John Vissing

Publikováno v: Annals of Neurology; Aug2004, Vol. 56 Issue 2, p279-283, 5p